What Researchers Did
The researchers measured blood levels of a growth factor called IGF-1 in 48 patients with diabetic foot ulcers who were treated with hyperbaric oxygen therapy (HBOT), and compared patients whose wounds healed with those whose wounds did not.
What They Found
In this study of 48 consecutive patients with diabetic foot ulcers treated with HBOT, average IGF-1 levels rose with treatment, and the rise was significantly larger in patients whose wounds healed (p less than 0.001). Starting IGF-1 levels did not differ between the healed and non-healed groups (p = 0.399). The average IGF-1 level increased with HBOT overall (p less than 0.05). In the healed group, the average increase and the final values were significantly higher (p less than 0.05). In the non-healed group, the average IGF-1 change was negative and the final values were not significantly different.
What This Means for Canadian Patients
For people with diabetic foot ulcers, this study suggests that a rise in IGF-1 during HBOT went along with wound healing. The authors believe this rise may help predict who heals, but the abstract does not show that HBOT or IGF-1 caused the healing. It does not report HBOT pressures or the number of sessions.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
All 48 patients received HBOT and the abstract reports no untreated comparison group, so it cannot show that HBOT caused either the IGF-1 rise or the healing.